Patients who had their tumors expressing a high-level of OPN were stratified into two groups based on their survival status (alive or deceased). Differential expressions of different probesets between patients in the OPN high-alive subgroup and those in the OPN high-deceased subgroup were identified as described above.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.